Sensome

Sensome develops micro-sensor technology and proprietary integration processes that embed tissue-sensing capabilities into minimally invasive medical devices. The technology transforms in situ bio-impedance measurements into real-time insights to assist physicians in treatment decisions for acute ischemic stroke, lung cancer biopsies, and peripheral vascular interventions. Their flagship product, the Clotild Smart Guidewire System, provides real-time blood clot characterization during neurovascular procedures.